BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27551543)

  • 1. Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic.
    Zhou JY; Zhang Z; Qian GS
    Cell Death Discov; 2016; 2():16055. PubMed ID: 27551543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.
    Davey GC; Patil SB; O'Loughlin A; O'Brien T
    Front Endocrinol (Lausanne); 2014; 5():86. PubMed ID: 24936198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived mesenchymal stem cells improve the functioning of neurotrophic factors in a mouse model of diabetic neuropathy.
    Kim BJ; Jin HK; Bae JS
    Lab Anim Res; 2011 Jun; 27(2):171-6. PubMed ID: 21826178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.
    Kim H; Kim JJ; Yoon YS
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):168-78. PubMed ID: 22236028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy.
    Oses C; Olivares B; Ezquer M; Acosta C; Bosch P; Donoso M; Léniz P; Ezquer F
    PLoS One; 2017; 12(5):e0178011. PubMed ID: 28542352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine pretreatment enhances neurogenic, angiogenic and immunomodulatory effects of MSCs on experimentally induced diabetic neuropathy.
    Abdelrahman SA; Samak MA; Shalaby SM
    Cell Tissue Res; 2018 Oct; 374(1):83-97. PubMed ID: 29687216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy of mesenchymal stem cells for diabetic neuropathy: A systematic review and meta-analysis of preclinical studies.
    Li Y; Yue G; Yu S; Cheng X; Cao Y; Wang X
    Front Bioeng Biotechnol; 2024; 12():1349050. PubMed ID: 38770273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment.
    Lu H; Wu X; Wang Z; Li L; Chen W; Yang M; Huo D; Zeng W; Zhu C
    J Surg Res; 2016 Oct; 205(2):464-473. PubMed ID: 27664897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy for diabetic neuropathy using adult stem or progenitor cells.
    Han JW; Sin MY; Yoon YS
    Diabetes Metab J; 2013 Apr; 37(2):91-105. PubMed ID: 23641349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapy improves diabetic cardiac autonomic neuropathy and decreases the inducibility of ventricular arrhythmias.
    Wang Y; Xue M; Xuan YL; Hu HS; Cheng WJ; Suo F; Li XR; Yan SH; Wang LX
    Heart Lung Circ; 2013 Dec; 22(12):1018-25. PubMed ID: 23850388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures.
    Morris AD; Dalal S; Li H; Brewster LP
    Surgery; 2018 Apr; 163(4):870-876. PubMed ID: 29395235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of brain-derived neurotrophic factor on mesenchymal stem cell-seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism.
    He S; Shen L; Wu Y; Li L; Chen W; Hou C; Yang M; Zeng W; Zhu C
    Tissue Eng Part A; 2015 Mar; 21(5-6):928-38. PubMed ID: 25316594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
    Zhu M; He X; Wang XH; Qiu W; Xing W; Guo W; An TC; Ao LQ; Hu XT; Li Z; Liu XP; Xiao N; Yu J; Huang H; Xu X
    Diabetologia; 2017 Sep; 60(9):1822-1833. PubMed ID: 28577176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells.
    Sávio-Silva C; Beyerstedt S; Soinski-Sousa PE; Casaro EB; Balby-Rocha MTA; Simplício-Filho A; Alves-Silva J; Rangel ÉB
    Stem Cells Int; 2020; 2020():8833725. PubMed ID: 33505469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
    Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogués C; Creane M; Chen X; Alagesan S; Owens P; Horan J; Dockery P; Griffin MD; Duffy A; O'Brien T
    Cell Transplant; 2018 Aug; 27(8):1210-1221. PubMed ID: 30016879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades.
    Evangelista AF; Vannier-Santos MA; de Assis Silva GS; Silva DN; Juiz PJL; Nonaka CKV; Dos Santos RR; Soares MBP; Villarreal CF
    J Neuroinflammation; 2018 Jun; 15(1):189. PubMed ID: 29933760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice.
    Ezquer M; Urzua CA; Montecino S; Leal K; Conget P; Ezquer F
    Stem Cell Res Ther; 2016 Mar; 7():42. PubMed ID: 26983784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards reaching the target: clinical application of mesenchymal stem cells for diabetic foot ulcers.
    Dash SN; Dash NR; Guru B; Mohapatra PC
    Rejuvenation Res; 2014 Feb; 17(1):40-53. PubMed ID: 24237303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.